Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(Salbutamol) about bronchodilating effect part and onset of relief of dyspnea.

Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(Salbutamol) about bronchodilating effect part and onset of relief of dyspnea. - Comparison study among FM/BUD(Formoterol/Budesonide), SM/FP (Salmeterol/Fluticasone), SB(salbutamol)about bronchodilating effect part and onset of relief of dyspnea.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009519

Enrollment

Registered

2013-01-01

Start date

2012-07-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adults who were induced bronchoconstriction by methacholine.

Interventions

Formoterol/Budesonide Salmeterol/Fluticasone Salbutamol Control(No treatment)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Male or female aged between 20 and 40 years. 2.The forced expiratory volume in one second has to at least 70 percent of predicted value.

Exclusion criteria

Exclusion criteria: 1.Aortic aneurysm 2.Pregnancy 3.History of cerebral infarction within three months. 4.Breast-feeding women 5.Hypertension 6.Diabetes mellitus 7.Hyperthyroidism 8.Cardiac disease

Design outcomes

Primary

Measure	Time frame
Respiratory impedance, Borg scale	—

Secondary

Measure	Time frame
FEV1.0, Lung capacity	—

Countries

Japan

Contacts

Public ContactYukinari Itoigawa

1978 Respiratory Medicine

yuitoiga@gmail.com03-5802-1063

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026